FDA Warns of Unapproved GLP-1 Weight-Loss Drugs

FDA Warns of Unapproved GLP-1 Weight-Loss Drugs

Silver Spring, MDOn December 18, 2024, the FDA issued a warning about the dangers of unapproved GLP-1 drugs which are often marketed as better/cheaper/stronger alternatives to Ozempic. Even branded Ozempic has been... Read more »
Home Privacy Policy Terms Of Use Anti Spam Policy Contact Us Affiliate Disclosure DMCA Earnings Disclaimer